Past Event

Tackling antimicrobial resistance (AMR)

Pathological microbes are increasingly resistant to antimicrobial treatments. The resulting health crisis is one of the greatest challenges facing society. At this event, Jim O'Neill will present the Independent Review on Antimicrobial Resistance and a panel will discuss how to tackle drug resistance.

Date: July 14, 2016, 12:30 pm Topic: Innovation & Competition Policy

Summary

See below for video and presentation.

The medical community has identified antimicrobial resistance as a major issue for human beings. In fact, drug resistance poses a threat to our future development and prosperity, as well as to our health. According to recent studies, the number of deaths attributable to AMR in 2050 could equal 10 million. The figure is alarming, making the estimated number of AMR deaths larger than the amount of victims attributable to cancer (8.2 million in 2050).

Because of its relevance, the AMR must also be treated as an economic issue, and the Review on Antimicrobial Resistance commissioned by the UK government in 2014 is playing a key role for this purpose. A ten-point plan has been developed in the Review for tackling AMR, with public awareness being on top of the list, since the problem is ignored in our society. In order to fight the issue, information campaigns should be carried out, as most people appear to have no clue of what antimicrobial resistance is and why it represents a huge threat. A rise in public awareness towards antimicrobial resistance would also bring results, if people proactively react to it. In fact, a way to reduce the impact of the problem is increasing sanitation and hygiene, which could be done by individuals and constitutes the most effective way of facing the issue.

The plan to tackle AMR suggests to stop using antibiotics in agriculture, environment and food processing. To this extent, more transparency from food producers and retailers and in the whole agricultural sector is needed. In general, our society has to increase surveillance on how antibiotics are used in these fields as well as in medicine. The reduction in use and prescriptions of antibiotics would limit the evolution of bacteria. Rapid and efficient diagnostics could also help: sometimes antibiotics are not useful in medical treatments, and the abuse in prescriptions can only worsen the issue. Antibiotics should only be prescribed if a diagnostic technique is used to prove to the necessity of their use. As an alternative, the medical community should boost the role of vaccines, which would partly reduce the use of antibiotics.

On the research side, new drugs should be developed, both to treat patients with pharmaceutical products other than antibiotics and to tackle antimicrobial resistance directly. However, this also requires an increase in investments in research and global innovation funding: funds from a multiplicity of international stakeholders should be allocated and spent on research in a coordinated and strategic way. It is important to emphasize that action to tackle AMR should be conducted on a global basis, and support to achieve international agreements on what has to be done is needed.

Just committing resources, however, does not lead to the solution of the problem itself. Efforts from policy makers can play a central role. The scarce attention of policy makers to date regarding AMR can be attributed to the low level of information and a missing economic quantification of the problem, both of which would increase the awareness of policy-makers towards it. Moreover, the European Commission also needs directives to clarify which roles it could play as a stakeholder and policy-maker and how it can act in order to influence global action.

As a final remark, we should keep in mind that if we are able, as a global society, to build up an effective and sustainable model for funding research, the issue of AMR can be handled and its impact reduced.

Event notes by Domenico Favoino, Research Assistant

VIDEO RECORDING


Event Materials

The Review on Antimicrobial Resistance: global solutions to drug-resistant infections | Presentation by Jim O’Neill

 

Speakers

James Anderson

Head of Corporate Government Affairs, GlaxoSmithKline

Sally Davies

Chief Medical Officer for England

Charles Knirsch

Vice President, Therapeutic Vaccines Program Lead, Vaccine Clinical Research and Development, Pfizer

Jim O‘Neill

Xavier Prats Monné

Director General, European Commission, DG SANTE

Karen E. Wilson

Former Non-resident Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Matilda Sevon

matilda.sevon@bruegel.org

Read about event

Upcoming Event

Jul
9
12:30

Should we revisit the patent system for pharmaceutical products?

Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.

Speakers: Margaret K. Kyle, Roberto Romandini, Bruno van Pottelsberghe, Amaryllis Verhoeven and Reinhilde Veugelers Location: Bruegel, Rue de la Charité 33, 1210 Brussels
Read article More on this topic

Blog Post

Robots, ICT and EU employment

Disruptive technologies based on ICT, robots, and artificial intelligence have transformed labour markets through their important effects on employment. As the number of industrial robots continues to rise, our results imply that some measures to facilitate workforce transition and accommodate the rise of automation might be needed to maintain satisfactory labour market outcomes.

By: David Pichler, Georgios Petropoulos and Francesco Chiacchio Topic: Innovation & Competition Policy Date: June 15, 2018
Read about event More on this topic

Past Event

Past Event

Protecting EU firms without protectionism

Do we need more effective support for EU companies, more targeted to threatened sectors of strategic importance to the EU? Do we need to revise our competition policy rules on state aid to allow for a more strategic industrial policy support? Do we need new policy approaches to prepare for a changing global environment?

Speakers: Vincent Aussilloux, Tomas Baert, Paolo Casini, Gert-Jan Koopman, André Sapir, Reinhilde Veugelers and Focco Vijselaar Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: May 3, 2018
Read article Download PDF More on this topic More by this author

Policy Contribution

Are European firms falling behind in the global corporate research race?

The author looks at how concentrated corporate R&D is in Europe, compared with sales and employment. The US and China are more likely to produce new R&D leaders that take over some of the top positions from incumbent R&D leaders. How is the EU coping with technology shifts and creating the next generation of new leading firms?

By: Reinhilde Veugelers Topic: Innovation & Competition Policy Date: April 12, 2018
Read about event More on this topic

Past Event

Past Event

Bank assets and business models: addressing complexity

At this event, we discussed the lack of transparency and problems in valuing correctly significant parts bank assets in the euro area based on an extensive study by the Bank of Italy.

Speakers: Simon Ainsworth, Paolo Angelini, Josina Kamerling, Martin Merlin, Alexander Lehmann and Nicolas Véron Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 21, 2018
Read about event More on this topic

Past Event

Past Event

The future of the EU budget: MFF post-2020

Which should be the priorities for the Multiannual Fiscal Framework post 2020?

Speakers: Roger Havenith, Günther H. Oettinger, Charlotte Ruhe, Margit Schratzenstaller-Altzinger and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 7, 2018
Read about event

Past Event

Past Event

(How) could European safe assets be constructed?

At this event we looked at the ESRB task force’s investigation on safe assets.

Speakers: Levin Holle, Sam Langfield, Anne A. Leclercq and Guntram B. Wolff Topic: European Macroeconomics & Governance, Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: March 1, 2018
Read about event More on this topic

Past Event

Past Event

Bruegel - Financial Times Forum: The future of euro-area governance

The third event in the Bruegel - Financial Times Forum series looked into the future of euro-area governance.

Speakers: Maria Demertzis, Gideon Rachman, Manfred Weber and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: February 27, 2018
Read about event More on this topic

Past Event

Past Event

Is there life After TTIP? The future of transatlantic economic relations

The partnership between North America and Europe is becoming unsettled and uncertain. How can we deal with this new situation that threatens the prosperity and ultimately the position of North America and Europe in the global economy.

Speakers: Maria Demertzis, Daniel S. Hamilton, Luisa Santos and André Sapir Topic: Global Economics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: February 19, 2018
Read about event More on this topic

Past Event

Past Event

The implications of Blockchain platforms

The disruptive forces of block chain technologies in markets and industries: a European perspective

Speakers: Anna Dimitrova, Julio Faura, Georgios Petropoulos, Johan Pouwelse and Pēteris Zilgalvis Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: February 6, 2018
Read about event More on this topic

Past Event

Past Event

Europe’s immigration and integration challenges: Financial and labour market dimensions

The event, organised by Bruegel in cooperation with the Institute for International Affairs will discuss these and related questions and will also feature the launch in Rome of the study authored by Zsolt Darvas on the impact and integration of migrants in the European Union.

Speakers: Roberto Ciciani, Zsolt Darvas, Marcela Escobari, Tatiana Esposito, Manjula M. Luthria, Carlo Monticelli, James Politi and Nathalie Tocci Topic: European Macroeconomics & Governance Location: Banca Monte dei Paschi di Siena, Via Mighetti 30/A, Rome, Italy Date: February 2, 2018
Read about event More on this topic

Past Event

Past Event

Why think tanks matter in the era of digital and political disruptions

Bruegel is pleased to host this panel discussion as part of the global launch of the 2018 Global Go To Think Tank Index, published by the University of Pennsylvania’s Think Tanks and Civil Societies Program.

Speakers: Matt Dann, Shada Islam and Hlib Vyshlinsky Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: January 30, 2018
Load more posts